These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 12099170)
21. Modes of administration of morphine in cancer pain. Formulations of morphine sulphate are easily confused. Cavell GF BMJ; 1996 Sep; 313(7058):687-8. PubMed ID: 8811772 [No Abstract] [Full Text] [Related]
22. Pharmacokinetics of morphine 3-esters after oral administration in rabbits. Otter K; Mignat C; Heber D; Ziegler A Pharmazie; 2001 Jun; 56(6):471-4. PubMed ID: 11446167 [TBL] [Abstract][Full Text] [Related]
23. A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose. Velez de Mendizabal N; Jimenez-Mendez R; Cooke E; Montgomery CJ; Dawes J; Rieder MJ; Aleksa K; Koren G; Jacobo-Cabral CO; Gonzalez-Ramirez R; Castañeda-Hernandez G; Carleton BC Clin Pharmacokinet; 2015 Oct; 54(10):1083-90. PubMed ID: 25773480 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of an immediate and extended release oral morphine formulation utilizing the spheroidal oral drug absorption system in dogs. Aragon CL; Read MR; Gaynor JS; Barnhart MD; Wilson D; Papich MG J Vet Pharmacol Ther; 2009 Apr; 32(2):129-36. PubMed ID: 19290942 [TBL] [Abstract][Full Text] [Related]
25. Technology: Barriers to misuse. Dolgin E Nature; 2015 Jun; 522(7557):S60-1. PubMed ID: 26107099 [No Abstract] [Full Text] [Related]
26. Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure. Halbsguth U; Rentsch KM; Eich-Höchli D; Diterich I; Fattinger K Br J Clin Pharmacol; 2008 Dec; 66(6):781-91. PubMed ID: 18945270 [TBL] [Abstract][Full Text] [Related]
27. Stability of dilute oral morphine solution for neonatal abstinence syndrome. Sauberan J; Rossi S; Kim JH J Addict Med; 2013; 7(2):113-5. PubMed ID: 23370932 [TBL] [Abstract][Full Text] [Related]
28. Morphine pharmacokinetics and metabolism in humans. Enterohepatic cycling and relative contribution of metabolites to active opioid concentrations. Hasselström J; Säwe J Clin Pharmacokinet; 1993 Apr; 24(4):344-54. PubMed ID: 8491060 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations. Dohoo SE; Tasker RA Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447 [TBL] [Abstract][Full Text] [Related]
33. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients. Setnik B; Roland CL; Goli V; Sommerville K; Webster L J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs. KuKanich B; Lascelles BD; Papich MG J Vet Pharmacol Ther; 2005 Aug; 28(4):371-6. PubMed ID: 16050817 [TBL] [Abstract][Full Text] [Related]
35. Oral morphine dosing predictions based on single dose in healthy children undergoing surgery. Dawes JM; Cooke EM; Hannam JA; Brand KA; Winton P; Jimenez-Mendez R; Aleksa K; Lauder GR; Carleton BC; Koren G; Rieder MJ; Anderson BJ; Montgomery CJ Paediatr Anaesth; 2017 Jan; 27(1):28-36. PubMed ID: 27779356 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer. Mashayekhi SO; Ghandforoush-Sattari M; Routledge PA; Hain RD Biopharm Drug Dispos; 2009 Apr; 30(3):99-106. PubMed ID: 19260034 [TBL] [Abstract][Full Text] [Related]
37. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open-label trial. Narabayashi M; Saijo Y; Takenoshita S; Chida M; Shimoyama N; Miura T; Tani K; Nishimura K; Onozawa Y; Hosokawa T; Kamoto T; Tsushima T; Jpn J Clin Oncol; 2008 Apr; 38(4):296-304. PubMed ID: 18326541 [TBL] [Abstract][Full Text] [Related]
38. In vivo evaluation of a new sustained-release formulation of morphine. Araico A; Saadeddin A; Torres-Molina F; Peris JE Pharmazie; 2009 Oct; 64(10):653-5. PubMed ID: 19947167 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the pharmacokinetic profile and analgesic efficacy of oral morphine after total hip arthroplasty. Manoir BD; Bourget P; Langlois M; Szekely B; Fischler M; Chauvin M; Paci A; Fletcher D Eur J Anaesthesiol; 2006 Sep; 23(9):748-54. PubMed ID: 16723055 [TBL] [Abstract][Full Text] [Related]
40. Chemical characterization with XPS of the surface of polymer microparticles loaded with morphine. Morales ME; Ruiz MA; Oliva I; Oliva M; Gallardo V Int J Pharm; 2007 Mar; 333(1-2):162-6. PubMed ID: 17074455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]